These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 20026006)

  • 1. Cyclophilin D in mitochondrial pathophysiology.
    Giorgio V; Soriano ME; Basso E; Bisetto E; Lippe G; Forte MA; Bernardi P
    Biochim Biophys Acta; 2010; 1797(6-7):1113-8. PubMed ID: 20026006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Permeability transition in human mitochondria persists in the absence of peripheral stalk subunits of ATP synthase.
    He J; Carroll J; Ding S; Fearnley IM; Walker JE
    Proc Natl Acad Sci U S A; 2017 Aug; 114(34):9086-9091. PubMed ID: 28784775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mitochondrial ATP synthase is a negative regulator of the mitochondrial permeability transition pore.
    Pekson R; Liang FG; Axelrod JL; Lee J; Qin D; Wittig AJH; Paulino VM; Zheng M; Peixoto PM; Kitsis RN
    Proc Natl Acad Sci U S A; 2023 Dec; 120(51):e2303713120. PubMed ID: 38091291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxic preconditioning-induced mitochondrial protection is not disrupted in a cell model of mtDNA T8993G mutation-induced F1F0-ATP synthase defect: the role of mitochondrial permeability transition.
    Huang WY; Jou MJ; Peng TI
    Free Radic Biol Med; 2014 Feb; 67():314-29. PubMed ID: 24291231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mitochondrial permeability transition pore: molecular nature and role as a target in cardioprotection.
    Bernardi P; Di Lisa F
    J Mol Cell Cardiol; 2015 Jan; 78():100-6. PubMed ID: 25268651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting putative components of the mitochondrial permeability transition pore for novel therapeutics.
    Winquist RJ; Gribkoff VK
    Biochem Pharmacol; 2020 Jul; 177():113995. PubMed ID: 32339494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oligomycin-sensitivity conferring protein of mitochondrial ATP synthase: emerging new roles in mitochondrial pathophysiology.
    Antoniel M; Giorgio V; Fogolari F; Glick GD; Bernardi P; Lippe G
    Int J Mol Sci; 2014 Apr; 15(5):7513-36. PubMed ID: 24786291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophilin D as a drug target.
    Waldmeier PC; Zimmermann K; Qian T; Tintelnot-Blomley M; Lemasters JJ
    Curr Med Chem; 2003 Aug; 10(16):1485-506. PubMed ID: 12871122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the c subunit of the FO ATP synthase in mitochondrial permeability transition.
    Bonora M; Bononi A; De Marchi E; Giorgi C; Lebiedzinska M; Marchi S; Patergnani S; Rimessi A; Suski JM; Wojtala A; Wieckowski MR; Kroemer G; Galluzzi L; Pinton P
    Cell Cycle; 2013 Feb; 12(4):674-83. PubMed ID: 23343770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclophilin D Promotes Brain Mitochondrial F1FO ATP Synthase Dysfunction in Aging Mice.
    Gauba E; Guo L; Du H
    J Alzheimers Dis; 2017; 55(4):1351-1362. PubMed ID: 27834780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclophilin D deficiency attenuates mitochondrial F1Fo ATP synthase dysfunction via OSCP in Alzheimer's disease.
    Gauba E; Chen H; Guo L; Du H
    Neurobiol Dis; 2019 Jan; 121():138-147. PubMed ID: 30266287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Not all mitochondrial carrier proteins support permeability transition pore formation: no involvement of uncoupling protein 1.
    Crichton PG; Parker N; Vidal-Puig AJ; Brand MD
    Biosci Rep; 2009 Dec; 30(3):187-92. PubMed ID: 19622065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the mitochondrial permeability transition by cyclophilin D: moving closer to F(0)-F(1) ATP synthase?
    Chinopoulos C; Adam-Vizi V
    Mitochondrion; 2012 Jan; 12(1):41-5. PubMed ID: 21586346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death.
    Baines CP; Kaiser RA; Purcell NH; Blair NS; Osinska H; Hambleton MA; Brunskill EW; Sayen MR; Gottlieb RA; Dorn GW; Robbins J; Molkentin JD
    Nature; 2005 Mar; 434(7033):658-62. PubMed ID: 15800627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. F1F0 ATP Synthase-Cyclophilin D Interaction Contributes to Diabetes-Induced Synaptic Dysfunction and Cognitive Decline.
    Yan S; Du F; Wu L; Zhang Z; Zhong C; Yu Q; Wang Y; Lue LF; Walker DG; Douglas JT; Yan SS
    Diabetes; 2016 Nov; 65(11):3482-3494. PubMed ID: 27554467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic targeting or genetic deletion of mitochondrial cyclophilin D protects from NSAID-induced small intestinal ulceration in mice.
    LoGuidice A; Ramirez-Alcantara V; Proli A; Gavillet B; Boelsterli UA
    Toxicol Sci; 2010 Nov; 118(1):276-85. PubMed ID: 20668000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial targeting of cyclosporin A enables selective inhibition of cyclophilin-D and enhanced cytoprotection after glucose and oxygen deprivation.
    Malouitre S; Dube H; Selwood D; Crompton M
    Biochem J; 2009 Dec; 425(1):137-48. PubMed ID: 19832699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic manipulation of the cardiac mitochondrial phosphate carrier does not affect permeability transition.
    Gutiérrez-Aguilar M; Douglas DL; Gibson AK; Domeier TL; Molkentin JD; Baines CP
    J Mol Cell Cardiol; 2014 Jul; 72():316-25. PubMed ID: 24768964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antamanide, a derivative of Amanita phalloides, is a novel inhibitor of the mitochondrial permeability transition pore.
    Azzolin L; Antolini N; Calderan A; Ruzza P; Sciacovelli M; Marin O; Mammi S; Bernardi P; Rasola A
    PLoS One; 2011 Jan; 6(1):e16280. PubMed ID: 21297983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anastrozole-mediated modulation of mitochondrial activity by inhibition of mitochondrial permeability transition pore opening: an initial perspective.
    Kumar S; Choudhary N; Faruq M; Kumar A; Saran RK; Indercanti PK; Singh V; Sait H; Jaitley S; Valis M; Kuca K; Polipalli SK; Kumar M; Singh T; Suravajhala P; Sharma R; Kapoor S
    J Biomol Struct Dyn; 2023; 41(23):14063-14079. PubMed ID: 36815262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.